医学
社会心理的
超重
随机对照试验
体质指数
儿童肥胖
肥胖
人口
减肥
干预(咨询)
心理干预
物理疗法
儿科
家庭医学
精神科
环境卫生
病理
外科
内科学
作者
Amanda E. Staiano,Alyssa M. Button,Alison Baker,Robbie A. Beyl,Anne‐Marie Conn,Angela Lima,Jeanne Lindros,Robert L. Newton,Richard I. Stein,R. Robinson Welch,Stephen Cook,Denise E. Wilfley
标识
DOI:10.1016/j.cct.2024.107459
摘要
Family-based behavioral treatment (FBT) is an effective intensive health behavior and lifestyle treatment for obesity reduction in children and adolescents, but families have limited access. The purpose of this randomized, pragmatic, comparative effectiveness trial was to examine changes in child relative weight in a 12-month, enhanced standard of care (eSOC) intervention combined with FBT (eSOC+FBT) vs. eSOC alone. Children aged 6 to 15 years with obesity, and their primary caregiver, were recruited from primary care clinics. Families were randomized 1:1 to eSOC, a staged approach led by the primary care provider that gradually intensified dependent on a child's response to care and aligns with the American Medical Association guidelines, or the eSOC+FBT arm, which included regular meetings with a health coach for healthy eating, physical activity, positive parenting strategies, and managing social and environmental cues. Both treatments align with the 2023 American Academy of Pediatrics clinical practice guidelines. Assessments occurred at baseline, midpoint (month 6), end-of-intervention (month 12), and follow-up (month 18). Primary outcome was change from baseline to 12 months in child percent overweight (percentage above the median body mass index in the general US population normalized for age and sex). Secondary outcomes were parent weight, child psychosocial factors, heterogeneity of treatment effects, and cardiometabolic risk factors. Exploratory outcomes assessed reach, effectiveness, adoption, implementation, and maintenance. This pragmatic trial will generate evidence for the comparative effectiveness of implementing two guidelines-based approaches in primary care for obesity reduction in children and adolescents. Trial registration: ClinicalTrials.gov Identifier: NCT03843424
科研通智能强力驱动
Strongly Powered by AbleSci AI